1. Sexually Transmitted Disease Surveillance 2009
National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention
Division of STD Prevention

2. Chlamydia—Rates by Sex, United States, 1990–2009
2008
2006
2004
2002
2000
1998
1996
1994
1992
1990
Total
Women
Men
100
200
300
400
500
600
Rate (per 100,000 population)
Year
NOTE: As of January 2000, all 50 states and the District of Columbia had regulations that required chlamydia cases to be reported.

3. Chlamydia—Rates by State, United States and Outlying Areas, 2009VT NH MA RI CT NJ DE MD DC
<300.0
(n = 10)
300.1–400.0
(n = 21)
>400.0
(n = 23)
327
303
399
386
309
753
305
185
472
346
595
435
252
225
478
369
375
272
372
803
556
411
398
445
420
457
341
438
413
626
503
469
311
199
405
400
468
313
Puerto Rico
Guam
352
Rate per 100,000
population
Virgin
Islands
444
191
160
297
344
276
540
422
1,107
NOTE: The total rate of chlamydia for the United States and outlying areas (Guam, Puerto Rico, and Virgin Islands) was per 100,000 population.

4. Chlamydia—Rates by County, United States, 2009
Rate per 100,000
population
<300.0
(n = 2,052)
300.1–400.0
(n = 379)
>400.0
(n = 710)

5. Chlamydia—Rates by Age and Sex, United States, 2009
3,800
3,040
2,280
1,520
760
10–14
15–19
20–24
25–29
30–34
35–39
40–44
45–54
55–64
65+
Total
13.8
735.5
1,120.6
573.3
286.0
141.3
81.9
36.0
219.8
2.9
11.0
127.9
3,329.3
3,273.9
1,234.0
511.7
205.8
88.4
32.0
593.4
2.1
9.1
Men
Women
Rate (per 100,000 population)
Age

6. Chlamydia—Prevalence by Age Group and Race/Ethnicity, National Health and Nutrition Examination Survey, 1999–2002
Non-Hispanic Blacks
Non-Hispanic Whites
Mexican-Americans 4 8 12 16
30–39
20–29
14–19
Prevalance, %
Age
NOTE: Error bars indicate 95% confidence intervals.
SOURCE: Datta SD, Sternberg M, Johnson RE, Berman S, Papp JR, McQuillan G, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to Ann Intern Med. 2007;147(2):89-96.

7. Chlamydia—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2009
6.3
5.4
6.9
8.1
6.2
5.9
Puerto Rico
10.0
Virgin
Islands
15.5
4.7
5.3
6.4
11.1
12.3
6.6
14.4
7.5
6.7
6.5
8.9
13.7
10.8
8.6
7.8
7.2
8.2
8.8
6.0
8.7
7.0
13.1
10.7
4.4
7.7
9.7
6.8
<5.0
(n = 4)
Positivity, %
5.0–9.9
(n = 38)
>10.0
(n = 11) VT NH MA RI CT NJ DE MD DC
3.5
3.7
8.3
9.2
6.1
NOTE: Includes states and outlying areas that reported chlamydia positivity data on at least 500 women aged 15–24 years who were screened during 2009

8. Gonorrhea Sexually Transmitted Disease Surveillance 2009
Division of STD Prevention

9. Gonorrhea—Rates, United States, 1941–2009
Rate (per 100,000 population)
2006
2001
1996
1991
1986
1981
1976
1971
1966
1961
1956
1951
1946
1941
100
200
300
400
500
Year

10. Gonorrhea—Rates by State, United States and Outlying Areas, 2009
34.9
29.4
63.2
66.4
8.3
144.3
Puerto Rico
5.8
Guam
33.5
23.5
10.9
87.2
81.4
185.7
120.4
7.2
12.5
54.5
13.9
42.8
77.2
44.1
92.4
246.4
160.8
141.3
113.9
150.4
100.3
139.2
147.0
107.2
127.5
109.8
128.3
204.0
156.2
154.7
89.6
26.2
57.2
50.0
55.2
89.4
<19.0
(n = 8)
Rate per 100,000
population
19.1–100.0
(n = 24)
>100.0
(n = 22)
49.0
Virgin
Islands
104.7 VT NH MA RI CT NJ DE MD DC
8.0
8.6
30.4
30.6
73.1
54.8
111.2
113.5
432.7
NOTE: The total rate of gonorrhea for the United States and outlying areas (Guam, Puerto Rico, and Virgin Islands) was 97.8 per 100,000 population.

11. Gonorrhea—Rates by County, United States, 2009
<19.0
(n = 1,405)
Rate per 100,000
population
19.1–100.0
(n = 1,129)
>100.0
(n = 607)

12. Gonorrhea—Rates by Age and Sex, United States, 2009
750
600
450
300
150
10–14
15–19
20–24
25–29
30–34
35–39
40–44
45–54
55–64
65+
Total
5.0
250.0
407.5
238.9
145.0
85.6
60.8
33.6
92.2
2.7
11.4
25.3
568.8
555.3
229.4
106.2
47.6
22.9
8.7
105.7
0.5
2.1
Men
Women
Rate (per 100,000 population)
Age

13. Gonorrhea—Rates by Race/Ethnicity, United States, 2000–2009
100
200
300
400
500
600
700
800
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Whites
Hispanics
Blacks
Asians/Pacific Islanders
American Indians/Alaska Natives
Rate (per 100,000 population)
Year

14. Gonorrhea—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2009
1.0
3.4
1.1
0.2
Puerto Rico
0.1
Virgin
Islands
2.0
0.0
0.5
0.8
0.3
1.6
0.4
2.7
2.4
1.8
1.2
1.4
0.6
2.1
1.9 *
(n = 4)
Positivity (%)
<1.0
(n = 24)
1.0–1.9
(n = 16)
>2.0
(n = 9) VT NH MA RI CT NJ DE MD DC
1.3
2.5
* States/areas not meeting minimum inclusion criteria.
NOTE: Includes states and outlying areas that reported positivity data on at least 500 women aged 15–24 years who were screened during 2009.

15. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Ceftriaxone Among GISP Isolates, 2005–2009 20 40 60 80
100
0.25
0.125
0.06
0.03
0.015
<0.008
2006
2005
Percentage
2007
2009
2008
MICs (µg/ml)

16. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Azithromycin Among GISP Isolates, 2005–2009 10 20 30 40 16 8 4 2 1
0.5
0.25
0.125
0.06
<0.03
2006
2005
Percentage
2007
2009
2008
MICs (µg/ml)

17. Gonococcal Isolate Surveillance Project (GISP)—Percentage of Neisseria gonorrhoeae Isolates with Resistance or Intermediate Resistance to Ciprofloxacin, 1990–2009 5 10 15 20
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
Intermediate Resistance
Resistance
Percentage
Year
NOTE: Resistant isolates have ciprofloxacin minimum inhibitory concentrations (MICs) >1 µg/ml. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125–0.5 µg/ml. Susceptibility to ciprofloxacin was first measured in GISP in 1990.

18. Syphilis Sexually Transmitted Disease Surveillance 2009
Division of STD Prevention

19. Syphilis—Reported Cases by Stage of Infection, United States, 1941–2009

20. Primary and Secondary Syphilis—Rates by State, United States and Outlying Areas, 2009
<0.2
(n = 5)
0.21–2.2
(n = 19)
>2.2
(n = 30)
2.1
1.5
5.2
3.5
0.4
0.0
0.6
0.3
6.1
2.7
6.8
0.2
1.1
3.1
1.4
0.8
8.1
8.9
9.8
5.7
6.3
3.8
2.3
2.5
6.5
2.9
16.8
9.6
5.8
2.2
3.6
2.6
Puerto Rico
Guam
Rate per 100,000
population
Virgin
Islands VT NH MA RI CT NJ DE MD DC
3.7
1.9
2.4
5.6
27.5
NOTE: The total rate of primary and secondary syphilis for the United States and outlying areas (Guam, Puerto Rico, and Virgin Islands) was 4.6 per 100,000 population.

21. Primary and Secondary Syphilis—Rates by County, United States, 2009
<0.2
(n = 2,196)
Rate per 100,000
population
0.21–2.2
(n = 353)
>2.2
(n = 592)
NOTE: In 2009, a total of 2,194 (69.9%) of 3,141 counties in the United States reported no cases of primary and secondary syphilis.

22. Primary and Secondary Syphilis—Rates by Age and Sex, United States, 200925 20 15 10 5
10–14
15–19
20–24
25–29
30–34
35–39
40–44
45–54
55–64
65+
Total
0.0
6.0
20.7
18.5
15.8
13.3
13.7
8.3
7.8
0.5
2.9
0.2
3.3
5.6
3.6
3.0
1.9
1.6
1.0
1.4
Men
Women
Rate (per 100,000 population)
Age

23. Primary and Secondary Syphilis—Reported Cases
Primary and Secondary Syphilis—Reported Cases* by Stage, Sex, and Sexual Behavior, United States, 2009
MSM†
Women
Secondary
Primary
Cases
1,000
2,000
3,000
4,000
5,000
6,000
MSW†
* Of the reported male cases of primary and secondary syphilis, 20% were missing sex of sex partner information.
† MSW = men who have sex with women only; MSM = men who have sex with men.

24. Other Sexually Transmitted Diseases
Sexually Transmitted Disease Surveillance 2009
Division of STD Prevention

25. Chancroid—Reported Cases, United States, 1981–20091 2 3 4 5
2009
2007
2005
2003
2001
1999
1997
1995
1993
1991
1989
1987
1985
1983
1981
Cases (in thousands)
Year

26. Human Papillomavirus—Prevalence of High-risk and Low-risk Types Among Females Aged 14–59 Years, National Health and Nutrition Examination Survey, 2003–2004 5 10 15 20 25 30 35 40 45
50–59
40–49
30–39
25–29
20–24
14–19
Low-risk HPV*
Prevalence, %
High-risk HPV
Age
* HPV = human papillomavirus.
NOTE: Error bars indicate 95% confidence intervals. Both high-risk and low-risk HPV types were detected in some females.
SOURCE: Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection
among females in the United States. JAMA. 2007;297(8):813-9.
Copyright ©2007 American Medical Association. All rights reserved.

27. Genital Warts—Initial Visits to Physicians’ Offices, United States, 1966–2009
100
200
300
400
500
2008
2005
2002
1999
1996
1993
1990
1987
1984
1981
1978
1975
1972
1969
1966
Visits (in thousands)
Year
NOTE: The relative standard errors for genital warts estimates of more than 100,000 range from 18% to 30%.
SOURCE: IMS Health, Integrated Promotional Services™. IMS Health Report, 1966–2009.

28. Genital Herpes—Initial Visits to Physicians’ Offices, United States, 1966–200950
100
150
200
250
300
350
400
Visits (in thousands)
Year
2008
2005
2002
1999
1996
1993
1990
1987
1984
1981
1978
1975
1972
1969
1966
NOTE: The relative standard errors for genital herpes estimates of more than 100,000 range from 18% to 30%.
SOURCE: IMS Health, Integrated Promotional Services™. IMS Health Report, 1966–2009.